Narrow search
Showing 1 - 10 of 655
Cover Image
Advertising regulations in pharmaceutical markets : product versus enlightenment
Ishida, Junichiro; Takahara, Tsuyoshi - 2019
This paper analyzes the optimal content regulation of direct-to-consumer advertisement (DTCA) in a pharmaceutical … promote their own specific products under product DTCA, whereas they can only advertise the presence of a disease and its … typical subjective symptoms under enlightenment DTCA. The content regulation changes the nature of market competition and the …
Persistent link: https://www.econbiz.de/10012024745
Cover Image
Hospitals and the generic versus brand-name prescription decision in the outpatient sector
Pruckner, Gerald J.; Schober, Thomas - 2016
Healthcare payers try to reduce costs by promoting the use of cheaper generic drugs. We show strong interrelations in drug prescriptions between the inpatient and outpatient sectors by using a large administrative dataset from Austria. Patients with prior hospital visits have a significantly...
Persistent link: https://www.econbiz.de/10011570769
Cover Image
Advertising Regulations in Pharmaceutical Markets : Product versus Enlightenment
Ishida, Junichiro - 2019
This paper analyzes the optimal content regulation of direct-to-consumer advertisement (DTCA) in a pharmaceutical … promote their own specific products under product DTCA, whereas they can only advertise the presence of a disease and its … typical subjective symptoms under enlightenment DTCA. The content regulation changes the nature of market competition and the …
Persistent link: https://www.econbiz.de/10012897821
Cover Image
Umbrella Branding in Pharmaceutical Markets
Suppliet, Moritz - 2017
Umbrella branding is a marketing practice whereby multi-product firms leverage their reputation across different product categories. This paper investigates how advertising in the market of over-the-counter (OTC) drugs affects the decision to buy prescription drugs from a promoted brand name. I...
Persistent link: https://www.econbiz.de/10012947424
Cover Image
The Effect of Direct to Consumer Television Advertising on the Timing of Treatment
Bradford, David; Kleit, Andrew N.; Nietert, Paul; … - 2020
We examine how direct to consumer advertising (DCA) affects the delay between diagnosis and pharmacological treatment for patients suffering from a common chronic disease. The primary data for this study consist of patients diagnosed with osteoarthritis (N=18,235) taken from a geographically...
Persistent link: https://www.econbiz.de/10014062456
Cover Image
The Cost Effectiveness of Direct to Consumer Advertising for Prescription Drugs
Rubin, Paul H.; Atherly, Adam - 2014
In this paper we use published information to provide analyze the economic value of Direct to Consumer (DTC) advertising. We use information on: the effect of DTC in generating patient visits; the effect of patient visits and mentions of a drug in generating prescriptions; and the effect of...
Persistent link: https://www.econbiz.de/10014047829
Cover Image
The Effects of Detailing on Prescribing Decisions Under Quality Uncertainty
Ching, Andrew T.; Ishihara, Masakazu - 2010
Motivated by recent empirical findings on the relationship between new clinical evidence and the effectiveness of detailing, this paper develops a new structural model of detailing and prescribing decisions under the environment where both manufacturers and physicians are uncertain about drug...
Persistent link: https://www.econbiz.de/10014048404
Cover Image
Should product-specific advertisement be regulated in pharmaceutical markets?
Ishida, Junichiro; Takahara, Tsuyoshi - 2022
This paper examines the optimal content regulation of DTCA by comparing two forms of DTCA-product-specific and category …-specific-and identifies a key tradeoff which underlies this policy debate. Our analysis suggests that the optimal form of DTCA depends … crucially on the cost effectiveness of DTCA and the market-size distortion induced by DTCA. When the cost of advertisement is …
Persistent link: https://www.econbiz.de/10013329470
Cover Image
Hospitals and the generic versus brand-name prescription decision in the outpatient sector
Pruckner, Gerald J.; Schober, Thomas - 2016
Healthcare payers try to reduce costs by promoting the use of cheaper generic drugs. We show that there are strong interrelations in drug prescriptions between the inpatient and the outpatient sector using a large administrative dataset from Austria. Patients with prior hospital visits have a...
Persistent link: https://www.econbiz.de/10011519140
Cover Image
The Effect of Price Caps on Pharmaceutical Advertising : Evidence from the 340b Drug Pricing Program
Hristakeva, Sylvia; Mortimer, Julie Holland; Yde, Eric - National Bureau of Economic Research - 2024
We study the effect of price caps on the provision of costly effort by pharmaceutical firms using variation in drug discounts generated by a price regulation program that allows eligible hospitals to purchase outpatient drugs at steep discounts. These discounts directly affect drug...
Persistent link: https://www.econbiz.de/10014512103